» Authors » Jose M Abascal

Jose M Abascal

Explore the profile of Jose M Abascal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 187
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Paesano N, Picola N, Munoz-Rodriguez J, Ruiz-Plazas X, Munoz-Rivero M, Celma A, et al.
Diagnostics (Basel) . 2025 Feb; 15(3). PMID: 39941218
: A transperineal approach to prostate biopsy is now recommended to reduce the risk of infectious complications associated with the transrectal route. Our aim is to compare the efficacy of...
2.
Morote J, Paesano N, Picola N, Munoz-Rodriguez J, Ruiz-Plazas X, Munoz-Rivero M, et al.
Life (Basel) . 2024 Nov; 14(11). PMID: 39598158
The role of digital rectal examination (DRE) in the early detection of significant prostate cancer (PCa) is being questioned in the era of magnetic resonance imaging (MRI). However, some men...
3.
Morote J, Paesano N, Picola N, Munoz-Rodriguez J, Ruiz-Plazas X, Munoz-Rivero M, et al.
Int Braz J Urol . 2024 Aug; 50(5):595-604. PMID: 39106115
Purpose: To validate the Barcelona magnetic resonance imaging predictive model (BCN-MRI PM) in men with pre-biopsy multiparametric MRI (mpMRI) reported with the Prostate Imaging Reporting and Data System (PI-RADS) v2.1,...
4.
Morote J, Paesano N, Picola N, Miro B, Abascal J, Servian P, et al.
Cancers (Basel) . 2024 Jul; 16(13). PMID: 39001369
Since the optimal scheme for targeted biopsies of magnetic resonance imaging (MRI) suspicious lesions remains unclear, we compare the efficacy of two schemes for these index lesions. A prospective trial...
5.
Morote J, Paesano N, Picola N, Munoz-Rodriguez J, Ruiz-Plazas X, Munoz-Rivero M, et al.
Eur Urol Open Sci . 2024 Jul; 66:5-8. PMID: 38988951
Patient Summary: We tested a method for assessing quality control for centers carrying out screening for early detection of prostate cancer. We found that the method can identify centers that...
6.
Morote J, Borque-Fernando A, Esteban L, Picola N, Munoz-Rodriguez J, Paesano N, et al.
World J Urol . 2024 Jul; 42(1):393. PMID: 38985325
Purpose: To validate the Barcelona-magnetic resonance imaging predictive model (BCN-MRI PM) for clinically significant prostate cancer (csPCa) in Catalonia, a Spanish region with 7.9 million inhabitants. Additionally, the BCN-MRI PM...
7.
Morote J, Picola N, Munoz-Rodriguez J, Paesano N, Ruiz-Plazas X, Munoz-Rivero M, et al.
Biomolecules . 2024 Feb; 14(2). PMID: 38397430
Concerns exist regarding the effects of 5-alpha reductase inhibitors (5-ARIs) on multipa-rametric magnetic resonance imaging (mpMRI) and clinically significant prostate cancer (csPCa) detection. Our objective is to analyze the effect...
8.
Morote J, Borque-Fernando A, Esteban L, Picola N, Munoz-Rodriguez J, Paesano N, et al.
Urol Oncol . 2024 Feb; 42(4):115.e1-115.e7. PMID: 38342654
Purpose: To analyze the reduction in multiparametric magnetic resonance imaging (mpMRI) demand and prostate biopsies after the hypothetical implementation of the Barcelona risk-stratified pathway (BCN-RSP) in a population of the...
9.
Morote J, Picola N, Munoz-Rodriguez J, Paesano N, Ruiz-Plazas X, Munoz-Rivero M, et al.
World J Mens Health . 2024 Jan; 42(2):441-448. PMID: 38164025
Purpose: To relate the prostate volume category (PVC) assessed with digital rectal examination (DRE)-small, median, and large-and the prostate volumes (PVs) assessed with magnetic resonance imaging (MRI) and transrectal ultrasound...
10.
Morote J, Picola N, Munoz-Rodriguez J, Paesano N, Ruiz-Plazas X, Munoz-Rivero M, et al.
Cancers (Basel) . 2023 Sep; 15(18). PMID: 37760511
The primary objective of this study was to analyse the current accuracy of targeted and systematic prostate biopsies in detecting csPCa. A secondary objective was to determine whether there are...